Taipei Medical University and TaiBear Health Announce Strategic Partnership to Revolutionize Chronic Kidney Disease Management with Predictive Artificial Intelligence

This collaboration, formalized ahead of the J.P. Morgan Healthcare Conference in Taipei, combines TMU’s massive longitudinal clinical de-identified datasets and clinical expertise with TaiBear Health’s proprietary AI platform. The initiative aims to equip risk-bearing populations with the precise clinical guidance needed to stabilize patient health and dismantle the compounding financial burden of late-stage disease.

“As both a nephrologist and a University President, I have long advocated for a healthcare ecosystem where data drives proactive care,” said Dr. Mai-Szu Wu, President of Taipei Medical University. “Our partnership with TaiBear Health represents the next frontier of this vision. By integrating TaiBear’s predictive intelligence with TMU’s clinical resources, we are moving beyond traditional diagnostics and advancing to identify high-risk patients before irreversible damage occurs. This is the true promise of smart healthcare: using technology to protect the humanity and quality of life of our patients.”

The partnership centers on developing and validating TaiBear’s “Rapid Progressor” CKD predictive models using TMU’s diverse de-identified patient data. This collaboration will accelerate the deployment of precision interventions aimed at mitigating CKD progression.

“We are honored to partner with Taipei Medical University, an institution synonymous with innovation and clinical excellence,” said Greer Myers, TaiBear Chief Executive Officer. “We don’t just analyze the data—we own the intelligence that changes the patient trajectory. Together with TMU, we are proving that predictive intelligence can intercept the chaotic progression of CKD and save lives.”

---

Look for More Information

TaiBear Health, Inc.  Website: www.taibear.ai

• About TaiBear Health, Inc.
  TaiBear Health is a New York-headquartered predictive intelligence company dedicated to preempting the chaotic progression of complex chronic diseases. Starting with Chronic Kidney Disease (CKD), the company uses proprietary neural network architectures and massive longitudinal datasets to move healthcare beyond static diagnostics into dynamic forecasting. TaiBear identifies “Rapid Progressors” early in their disease course, equipping risk-bearing entities with the precise guidance needed to stabilize patient health and avert the catastrophic financial toll. TaiBear delivers the intelligence to not just predict, but fundamentally alter the patient trajectory.